Anne Marie Comeau to Cystic Fibrosis Transmembrane Conductance Regulator
This is a "connection" page, showing publications Anne Marie Comeau has written about Cystic Fibrosis Transmembrane Conductance Regulator.
Connection Strength
1.317
-
Hale JE, O'Sullivan BP, Parad RB, Dorkin HL, Kremer TM, Vehse NW, Yonker LM, Sawicki GS, Counihan AM, Gerstel-Thompson J, Kumar B, Comeau AM. Expansion of variant panels in newborn screening algorithms to identify cystic fibrosis: A retrospective analysis of 25 years of genotypes and implications on diagnosis. Genet Med. 2026 Jan; 28(1):101629.
Score: 0.905
-
Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004 Jun; 113(6):1573-81.
Score: 0.205
-
Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S255-61.
Score: 0.078
-
O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R. Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics. 2006 Sep; 118(3):1260-5.
Score: 0.060
-
Parad RB, Comeau AM. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr. 2005 Sep; 147(3 Suppl):S78-82.
Score: 0.056
-
Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS. Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs. MMWR Recomm Rep. 2004 Oct 15; 53(RR-13):1-36.
Score: 0.013